User profiles for Bart Tarbet

Bart Tarbet

Utah State University
Verified email at usu.edu
Cited by 3117

[HTML][HTML] Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

…, JA Townsend, Y Hu, T Szeto, X Zhang, B Tarbet… - Cell research, 2020 - nature.com
A new coronavirus SARS-CoV-2, also called novel coronavirus 2019 (2019-nCoV), started
to circulate among humans around December 2019, and it is now widespread as a global …

Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L

…, X Zhang, Y Hu, N Kitamura, B Hurst, B Tarbet… - Science …, 2020 - science.org
The main protease (M pro ) of SARS-CoV-2 is a key antiviral drug target. While most M pro
inhibitors have a γ-lactam glutamine surrogate at the P1 position, we recently found that …

Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses

Y Hu, C Ma, T Szeto, B Hurst, B Tarbet… - ACS infectious …, 2021 - ACS Publications
As the COVID-19 pandemic continues to unfold, the morbidity and mortality are increasing
daily. Effective treatment for SARS-CoV-2 is urgently needed. We recently discovered four …

[HTML][HTML] Immunogenicity and efficacy of flagellin-fused vaccine candidates targeting 2009 pandemic H1N1 influenza in mice

G Liu, B Tarbet, L Song, L Reiserova, B Weaver… - PloS one, 2011 - journals.plos.org
We have previously demonstrated that the globular head of the hemagglutinin (HA) antigen
fused to flagellin of Salmonella typhimurium fljB (STF2, a TLR5 ligand) elicits protective …

Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5

TR Lane, J Fu, B Sherry, B Tarbet, BL Hurst… - Antiviral Research, 2023 - Elsevier
Enteroviruses (EV) cause a number of life-threatening infectious diseases. EV-D68 is known
to cause respiratory illness in children that can lead to acute flaccid myelitis. Coxsackievirus …

Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases

M Westberg, Y Su, X Zou, L Ning, B Hurst, B Tarbet… - bioRxiv, 2020 - biorxiv.org
The coronavirus main protease, M pro , is a key protein in the virus life cycle and a major
drug target. Based on crystal structures of SARSCoV2 M pro complexed with peptidomimetic …

Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses

…, RP Arya, L Bimler, S Paust, EB Tarbet… - Antiviral research, 2017 - Elsevier
The extracellular domain of influenza A ion channel membrane matrix protein 2 (M2e) is
considered to be a potential candidate to develop a universal influenza A vaccine. However …

[PDF][PDF] Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activity

…, R Roy, S King, MH Kaplan, IJ Goldstein, EB Tarbet… - Cell, 2015 - cell.com
A key effector route of the Sugar Code involves lectins that exert crucial regulatory controls
by targeting distinct cellular glycans. We demonstrate that a single amino-acid substitution in …

Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice

…, MH Wong, KW Bailey, EB Tarbet… - Antimicrobial agents …, 2010 - Am Soc Microbiol
Favipiravir (T-705 [6-fluoro-3-hydroxy-2-pyrazinecarboxamide]) and oseltamivir were
combined to treat influenza virus A/NWS/33 (H1N1), A/Victoria/3/75 (H3N2), and A/Duck/MN/1525/…

A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo

…, E Lipka, SE Evans, EB Tarbet… - Proceedings of the …, 2020 - National Acad Sciences
There is a strong need for a new broad-spectrum antiinfluenza therapeutic, as vaccination
and existing treatments are only moderately effective. We previously engineered a lectin, …